Associate Director, New Product Planning
About the role
At Rapport, we’re driven by a passion for developing precision neuromedicines with the potential for fewer side effects, enabling patients and their families to enjoy healthier, more fulfilling lives. Our innovative scientific platform is centered on Receptor Associate Proteins (RAPs). RAPs are a component of neuronal receptor complexes, which play a crucial role in regulating receptor assembly and function. This precision approach has the potential to revolutionize the development of small molecule therapies. We are excited about the potential of our lead program, RAP-219. Our first indication targets focal epilepsy with additional clinical trials in primary generalized tonic-clonic seizures (PGTCS) and bipolar disorder. The strength of Rapport comes from our Rapptors – who are united by our mission to improve patients lives. We bring the heart and hustle to advance our science forward, always staying true to our core values.
Responsibilities
- Build, maintain, and continuously refine multi-year commercial forecasts (epidemiology-based and analog-based) for pipeline assets across multiple indications and geographies
- Develop patient flow, market share, and pricing/access models to support investment decisions, licensing evaluations, and portfolio prioritization
- Stress-test forecast assumptions through sensitivity analyses and scenario planning; clearly communicate key drivers, risks, and uncertainty ranges
- Lead end-to-end opportunity assessments for early- and mid-stage pipeline assets, including market sizing, competitive landscape analysis, unmet need evaluation, and target product profile (TPP) development